Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

AGM Statement

17 Jun 2005 06:00

Embargoed Release: 07:00hrs 17th June 2005 SOPHEON PLC AGM Statement At the Annual General Meeting of Sopheon plc ("Sopheon") to be held latertoday, the Chairman of the board will give shareholders an update on thebusiness. This will include the following statement:"I am pleased to report that Sopheon continues to make significant strategicand operational advances in the pursuit of its core business goals. In ourupdate on Sopheon's first-quarter performance, published in April, we notedthat the period included revenue from three new Accolade license contracts andseven extension orders with existing customers for additional user licenses,consultancy or hosting services. There have been further successes during thesecond quarter, and we are endeavouring to close on several more contractsbefore the end of June. At the present time, our client base includes 57licensed customers, and Accolade is now being used in 48 countries around theglobe. These totals do not include stand-alone pilot or consultancy clients,nor users of our small scale lab solution in the Netherlands. I would like tohighlight two other points. First, customers have historically built up largelicense investments by adding users over time; last year, three customers eachcontracted for a license value in excess of $600,000 in a single transaction -two of these sales were concluded in the final days of 2004, highlighting thesignificant effect on our results of large individual contract wins. Second,our recurring maintenance base has doubled since the start of 2003, to ‚£1.1million as we entered 2005.The prospects for growth continue to be positive. A number of IT research andadvisory firms are forecasting that Product Portfolio Management (PPM) will beone of the fastest growing PLM categories during the next three years. Thismomentum is attracting increasing interest from traditional software vendors.Some are achieving market entry through M&A activity; others are looking toextend the functionality and content of their existing software suites toaddress PPM needs. We are confident that Accolade, with its deep domainstrength and specific out-of-the-box functionality, continues to lead themarket. In addition, Sopheon is actively developing partnerships to bolsterboth our strategic and channel strength in this changing competitive landscape.The alignment of Accolade with Microsoft technology is a key example of theseefforts, and the benefits have come through firmly in the latest release ofAccolade. Version 6.0 was a landmark release, supported by Microsoft both interms of R&D investment and marketing activity in Europe and America, and hasbeen very well received by market analysts. Having judged its CollaborativeProduct Development pilot initiative a business success, Microsoft is nowtaking steps to implement the program on a global scale and is also introducingseveral other potential partners to Sopheon.Our continued focus on growing our global ecosystem has resulted in agreementswith new reseller partners, including Deloitte & Touche in South Africa,Inogate in Portugal, Team Progress in New Zealand and Australia, and ASI inSouth Korea. In parallel with these developments, Sopheon has begun to pursue anumber of other partnering opportunities, and we have also given seriousconsideration to a small number of potential M&A transactions. I am pleased inthis context to announce today the signature of a letter of intent to augmentour relationship with Team Progress through a financial investment in theirSopheon reseller business. Further details of these initiatives will beannounced in due course.With the rate of market change growing in speed and complexity, and the volumeof competitor activity steadily escalating, we believe that it is essential toposition Sopheon to protect and extend its established lead in the PPM market.Two weeks ago we undertook a share placing on AIM, boosting our cash resourcesat the end of May to over ‚£2 million, to enable Sopheon to take timelyadvantage of opportunities for business expansion, and to act with strength inthe increasingly dynamic market environment."For further information contact:Barry Mence, Chairman Sopheon plc Tel : + 44 (0) 1483 685 735 Arif Karimjee, CFO Andrew Tan Hansard Communications Tel : + 44 (0) 207 245 1100 + 44 (0) 7957 203 685 Eva Lindner Citigate First Financial Tel : + 31 (0) 205 754 023 About SopheonSopheon (LSE:SPE) is an international provider of software and services thathelp organizations improve the business impact of product development. TheSopheon Accolade‚® product development system automates gate- or phase-basedproduct development (PD) processes and provides strategic decision support thatallows companies to improve innovation, cut product development spending wasteand shorten time to market. Sopheon is listed on the AIM market of the LondonStock Exchange and on the Euronext Amsterdam. For more information visit www.sopheon.com.ENDSOPHEON PLC
Date   Source Headline
30th Jan 201810:27 amRNSIssue of Equity
29th Jan 20187:00 amRNSTrading Update
4th Jan 20182:05 pmRNSSecond Price Monitoring Extn
4th Jan 20182:00 pmRNSPrice Monitoring Extension
4th Jan 20187:00 amRNSTrading Update
22nd Dec 20171:01 pmRNSHolding(s) in Company
22nd Dec 201712:37 pmRNSConversion of Loan Stock
8th Dec 20177:00 amRNSAmendment to the Terms of Convertible Loan Stock
9th Nov 20177:00 amRNSCertis Europe Partners with Sopheon
19th Oct 20177:00 amRNSSopheon Funding Award
11th Oct 201710:44 amRNSDirector/PDMR Shareholding
2nd Oct 20177:00 amRNSIssue of Equity
26th Sep 20177:00 amRNSSopheon "Leader" in Strategic Portfolio Management
5th Sep 20177:00 amRNSSopheon's Accolade Software beyond innovation
24th Aug 20177:00 amRNSHalf Yearly Report
21st Jul 201710:32 amRNSDirector Shareholdings
6th Jul 20177:00 amRNSAccolade Release 11.2
29th Jun 20177:00 amRNSNew Approach to Product Development with Accolade
13th Jun 201712:04 pmRNSDirector Shareholdings
8th Jun 201712:09 pmRNSResult of AGM
8th Jun 20177:00 amRNSAGM Statement
26th May 20174:33 pmRNSIssue of Equity
26th Apr 20173:50 pmRNSIssue of Equity
12th Apr 201712:01 pmRNSIssue of Equity
7th Apr 20171:37 pmRNSDirector Shareholdings
31st Mar 20177:00 amRNSDirector Shareholdings
31st Mar 20177:00 amRNSIssue of Equity
23rd Mar 20177:00 amRNSFinal Results
23rd Feb 20177:00 amRNSAccolade Release 11.1
16th Feb 20177:00 amRNSGrant of Options / PDMR dealing
30th Jan 20177:00 amRNSTrading Update
21st Nov 201611:50 amRNSIssue of Equity
3rd Nov 20168:00 amRNSAccolade Release 11.0
29th Sep 201612:41 pmRNSIssue of Equity
22nd Sep 20169:09 amRNSIssue of Equity
15th Sep 20163:09 pmRNSIssue of Equity
25th Aug 20167:00 amRNSHalf Yearly Report
28th Jul 20165:01 pmRNSHolding(s) in Company
26th Jul 201610:49 amRNSHolding(s) in Company
12th Jul 201610:48 amRNSHolding(s) in Company
29th Jun 20165:32 pmRNSDirector Dealing
16th Jun 20164:22 pmRNSDirector Dealing
14th Jun 20164:18 pmRNSDirector Dealing
10th Jun 20162:13 pmRNSDirector Dealing
9th Jun 201611:37 amRNSResult of AGM
9th Jun 20167:00 amRNSAGM Statement
31st May 20163:09 pmRNSIssue of Equity
5th May 20161:25 pmRNSHolding(s) in Company
4th May 20167:00 amRNSAccolade Release 10.3
3rd May 20161:27 pmRNSDirector Shareholdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.